ESC Premium Access

PREPARE-IT: Icosapent Ethyl Versus Placebo in People Exposed to COVID-19

Presentation

About the speaker

Doctor Rafael Diaz

Estudios Cardiologicos Latinoamerica (ECLA), Rosario (Argentina)
2 presentations
0 follower

3 more presentations in this session

Colchicine in Patients Hospitalized with COVID-19

Speaker: Doctor R. Diaz (Rosario, AR)

Thumbnail

The Michelle trial: Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy

Speaker: Doctor E. Ramacciotti (Santo Andre, BR)

Thumbnail

Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial

Speaker: Doctor M. Zile (Charleston, S C, US)

Thumbnail

Access the full session

Late Breaking Trials - COVID-19

Speakers: Doctor R. Diaz, Doctor R. Diaz, Doctor E. Ramacciotti, Doctor M. Zile
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by

logo Novo Nordisk